Toyosi Onwuemene/LinkedIn
Jun 11, 2026, 16:25
Toyosi Onwuemene: What Clinicians Reveal About Bleeding and Clotting Care
Toyosi Onwuemene, Associate Professor with tenure Duke University School of Medicine, shared a post on LinkedIn:
”A patient developed a pulmonary embolism.
He was started on anticoagulation.
Two days later, he developed gastrointestinal bleeding.
Anticoagulation was stopped.
Multiple specialists became involved.
One question remained:
When should anticoagulation be restarted?
It seemed like a straightforward question.
Yet, no one owned the decision.
In the latest edition of Hematology Access Insights, I explore what clinician interviews revealed about expertise, access, and decision-making in bleeding and clotting care.”
Proceed to the video attached to the post.
Stay updated with Hemostasis Today.
-
Jun 11, 2026, 16:20Tejas Ahire: Rh Incompatibility – A Small Blood Group Difference with Big Clinical Impact
-
Jun 11, 2026, 16:19Jack Shuang Hou: Bayer Advances Asundexian as EMA Reviews New Option for Preventing Recurrent Ischemic Stroke
-
Jun 11, 2026, 15:50Shatri Albertina: New Publication on DVT Among Surgical Patients Receiving Thromboprophylaxis
-
Jun 11, 2026, 15:48Ghada Eladly: The Classic Triad of Hemolytic Uremic Syndrome
-
Jun 11, 2026, 15:45D-Dimer Testing in Prolonged VTE Symptoms – Should We Really Be More Cautious? – RPTH Journal
-
Jun 11, 2026, 15:42Arun V J: Bringing Generative AI to India’s Largest Transfusion Medicine Gathering
-
Jun 11, 2026, 15:40Hugo Pin: Laser and Foam Therapy for Large Varicose Veins
-
Jun 11, 2026, 15:18Daniel Ben-Mordechay: The Critical Role of Ultrasound in Early Detection of DVT
-
Jun 11, 2026, 15:10Jane Olivier: The Power of Point-of-Care Ultrasound